v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Total revenue $ 572 $ 6,865 $ 11,658 $ 43,494
Operating expenses:        
Research and development 5,402 13,413 12,807 32,455
General and administrative 3,466 5,195 7,197 10,997
Total operating expenses 8,868 18,608 20,004 43,452
Income/(loss) from operations (8,296) (11,743) (8,346) 42
Interest and other income, net 130 365 239 820
Interest and other expense, net (38) (1,189) (69) (2,584)
Gain on extinguishment of debt   1,795   1,795
Change in valuation of contingent value right (Note 4) 107 303 651 303
Loss on disposal of property and equipment   (399)   (399)
Net loss attributable to common stockholders $ (8,097) $ (10,868) $ (7,525) $ (23)
Net loss per share attributable to common stockholders:        
Basic (in dollars per share) $ (1.23) $ (2.89) $ (1.26) $ (0.01)
Diluted (in dollars per share) $ (1.23) $ (2.89) $ (1.26) $ (0.01)
Weighted average number of shares used in net loss per share calculations:        
Basic (in shares) 6,557,295 3,756,711 5,965,781 3,756,711
Diluted (in shares) 6,557,295 3,756,711 5,965,781 3,756,711
Research and development revenue        
Total revenue $ 189 $ 6,627 $ 11,113 $ 40,254
Grant revenue        
Total revenue $ 383 $ 238 $ 545 $ 3,240

Source